跳至主要内容
临床试验/CTRI/2026/01/100364
CTRI/2026/01/100364尚未招募不适用

An Open Label Randomized Comparative Clinical Study To Evaluate The Efficacy Of Krushnatila Kwath Orally And Krushnatil Taila Matra Basti In The Management of Artavakshaya With special reference to Oligomenorrhea

Ashvini Subhashrao Bade2 个研究点 分布在 1 个国家目标入组 100 人开始时间: 2026年1月26日最近更新:

试验速览

阶段
不适用
状态
尚未招募
发起方
入组人数
100
试验地点
2

研究概览

简要总结

This is open label randomized comparative clinical study

Group A patient will treated by Krushntil kwath 40 ml twice in a day orally for 7 days from 21st day of  menstruation phage  in three consecutive menstrual cycles  in Artavkshya .

Group B patient will treated by krushnatil tail matra basti 60 ml rectally for 7 days from 21st day of menstruation phage in three consecutive menstrual cycles in Artavkshay

after collected data appropriate statistical test will apply and result will drown.

研究设计

研究类型
Interventional
分配方式
Coin toss, Lottery, toss of dice, shuffling cards etc
盲法
None

入排标准

年龄范围
18.00 Year(s) 至 35.00 Year(s)(—)
性别
Female

入选标准

  • patients suffering with two or more cardinal symptoms of Artavakshaya Patient Associated of Polycystic ovarian morphology.

排除标准

  • Pregnant And Lactating women Women ON oral contraceptive pill and Intrauterine Contraceptive Devices Congenital anomalies of uterus or ovaries Patients with systematic disease like Hypertension Diabetes Mellites Tuberculosis Women with pelvic Pathology and Malignancy Haemoglobin less than 8gm Patients contraindicated for Matrabasti.

研究者

发起方
Ashvini Subhashrao Bade
申办方类型
Other [self]
责任方
Principal Investigator
主要研究者

Dr Ashvini Subhashrao Bade

DR J J Magdum Ayurved Medical College

研究点 (2)

Loading locations...

相似试验